Semaglutide
A GLP-1 receptor agonist commonly evaluated for medical weight management and metabolic support.
Semaglutide is A GLP-1 receptor agonist commonly evaluated for medical weight management and metabolic support. Whether it is appropriate depends on your medical history, goals, current medications, and testing — evaluated by a licensed VidaVital Medical provider during a live consultation. Educational content only; not medical advice.
- Semaglutide is an FDA-approved medication.
- Baseline labs are generally required before a provider considers this therapy.
- Providers may evaluate it in weight-management, metabolic-health.
- A licensed VidaVital provider must complete a live consultation before any treatment is prescribed.
What is it?
A GLP-1 receptor agonist commonly evaluated for medical weight management and metabolic support. A licensed provider reviews suitability, monitoring, and any needed testing during a live consultation.
What may it support?
- Appetite regulation
- Glycemic support
- Weight management
Where might it fit?
Bloodwork & monitoring
- CMP
- CBC
- Lipid panel
Potential side effects
- Injection-site reaction
- Mild GI discomfort
- Rare allergic reaction
Who may not be a candidate?
- • Pregnancy
- • Active malignancy without oncology clearance
Drug interactions
- • Providers review all medications during consultation
Regulatory disclosures
FDA-approved for type 2 diabetes and chronic weight management under specific criteria.
Speak With a Licensed Medical Provider
If you're interested in learning whether peptide therapy may be appropriate for your health goals, schedule a consultation with a licensed VidaVital Medical provider. Your provider will review your medical history, discuss available treatment options, and determine whether any therapy is appropriate for your individual needs.
Frequently asked questions
Sources
- Provider-reviewed clinical summary — reviewed 2026-01-15 by VidaVital Medical